Is atrial fibrillation associated with increased mortality in hypertrophic cardiomyopathy? Results from the portuguese registry.

Back

ESC Premium Access

Is atrial fibrillation associated with increased mortality in hypertrophic cardiomyopathy? Results from the portuguese registry.

Session: Atrial fibrillation in hypertrophic cardiomyopathy

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor A. Lebreiro (Porto, PT)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Ana Margarida Lebreiro

Sao Joao Hospital, Porto (Portugal)

0 follower

5 more presentations in this session

Efficacy and safety of non-vitamin K oral anticoagulants in hypertrophic cardiomyopathy with non-valvular atrial fibrillation: a nationwide cohort study

Speaker: Doctor P. Yang (Seongnam, KR)

Left atrial remodelling in hypertrophic cardiomyopathy, contributing factors and associated outcomes

Speaker: Doctor S. Cuddy (Boston, US)

Impact of left atrial enlargement on very long-term outcomes in patients with hypertrophic cardiomyopathy

Speaker: Doctor Y. Azumi (Kobe, JP)

Access

Abstract

Atrial fibrillation in hypertrophic cardiomyopathy: clinical implications of an early detection through implanted cardioverter defibrillator

Speaker: Doctor R. Morgagni (Rome, IT)

Microvascular coronary disease and myocardial fibrosis within the spectrum of hypertrophic cardiomyopathy: a histopathologic study.

Speaker: Doctor A. Foa' (Boston, US)

Access the full session

Atrial fibrillation in hypertrophic cardiomyopathy

Speakers: Doctor A. Lebreiro, Doctor P. Yang, Doctor S. Cuddy, Doctor Y. Azumi, Doctor R. Morgagni...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources